Loading clinical trials...
Loading clinical trials...
Phase II Study of CGP 69846A (ISIS 5132) in Recurrent Epithelial Ovarian Cancer
Conditions
Interventions
ISIS 5132
Locations
66
United States
Duluth Clinic
Duluth, Minnesota, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Cross Cancer Institute
Edmonton, Alberta, Canada
Lethbridge Cancer Clinic
Lethbridge, Alberta, Canada
Burnaby Hospital Regional Cancer Centre
Burnaby, British Columbia, Canada
Penticton Regional Hospital
Penticton, British Columbia, Canada
Start Date
February 1, 1999
Primary Completion Date
October 17, 2000
Completion Date
September 22, 2008
Last Updated
April 6, 2020
NCT03050268
NCT06257264
NCT06964009
NCT00539162
NCT06710548
NCT05005403
Lead Sponsor
NCIC Clinical Trials Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions